Viewing Study NCT03276156


Ignite Creation Date: 2025-12-24 @ 11:18 PM
Ignite Modification Date: 2026-01-05 @ 5:48 PM
Study NCT ID: NCT03276156
Status: UNKNOWN
Last Update Posted: 2017-09-08
First Post: 2017-09-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancer
Sponsor: Zhejiang Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module